About
Liliya Euro is a Finnish biomedical researcher associated with the University of Helsinki whose work focuses on NAD metabolites, mitochondrial biology, and age-related/metabolic disease measurement. University of Helsinki materials describe her as a key developer of the NADMED method and the future Chief Scientific Officer of the commercialization effort. She also appears as a speaker in longevity and biomarker forums, indicating a scientific ecosystem role rather than an investing one.
Areas of interest
longevitybiotechmedical diagnosticsmitochondrial biologymetabolismNAD biologybiomarkers of agingclinical research